Pulmonary medium vessel vasculitis in an 11 year old boy: Hughes Stovin syndrome as a variant of polyarteritis nodosa?
© de Vries et al; licensee BioMed Central Ltd. 2011
Received: 7 February 2011
Accepted: 4 August 2011
Published: 4 August 2011
We present the case of an 11-year-old boy presenting with haemoptysis, dyspnoea and weight loss as a manifestation of isolated pulmonary vasculitis, leading to pulmonary hypertension. He also appeared to have a longstanding dural venous sinus thrombosis. This rare presentation, especially in childhood, might represent a case of the seldomly reported Hughes-Stovin syndrome. The patient achieved remission after therapy with cyclophosphamide pulses and high-dose steroids. Based on the presented case and review of the literature, we propose that this syndrome might be a variant of polyarteritis nodosa. This report highlights diagnostic issues and describes a successful treatment regimen.
According to the EULAR/PRINTO/PReS consensus criteria vasculitis of childhood is classified as small, medium-sized or large vessel vasculitis, or 'other' . In childhood, pulmonary involvement is most frequently observed in vasculitis which preferentially affects small vessels, such as Wegener's granulomatosis, microscopic polyangiitis and Churg-Strauss syndrome. Pulmonary involvement is seldomly observed in large and medium vessel vasculitis, such as Takayasu arteritis, Kawasaki disease and polyarteritis nodosa (PAN) [1–3]. An exception is Behçet's disease (BD), in which the formation of pulmonary artery aneurysms occurs in 1-8% of adult BD patients. Similar rates have been found in pediatric case series [2, 4–6].
In this report we describe an eleven-year-old boy suffering from pulmonary medium sized vessel vasculitis, combined with dural venous sinus thrombosis. We highlight the difficulty in establishing a definite diagnosis in the context of current diagnostic criteria and discuss Hughes-Stovin syndrome (HSS) as a potential diagnosis. HSS is characterized by the combination of multiple bilateral pulmonary artery aneurysms and venous thrombosis, and has been suggested to be an incomplete variant of BD [5, 7]. We will review pediatric cases of HSS from the literature and discuss the possibility that it is rather a variant of PAN with specific pulmonary involvement, based on its clinical manifestations in relation to current diagnostic guidelines and its therapeutic response.
An 11-year-old boy was admitted to our hospital with cough, fatigue, and weight loss (~4 kg) of 4 months duration, and hemoptysis starting the day before admission. The past medical history was unremarkable. His mother was Spanish, his father Dutch. The family medical history was negative for autoinflammatory or autoimmune diseases.
Clinical examination was unremarkable other than a pale appearance. No oral or genital ulcers were present. Laboratory examination revealed elevated inflammatory parameters (ESR 59 mm/h (normal, 3-13 mm/h); CRP 69 mg/L (normal < 5 mg/L); leucocytes 12.2*109/L (normal, 4.0-10.0*109/L); microcytic anemia (Hemoglobin 6.2 mmol/L (normal, 6.6-9.3 mmol/L); MCV 65.9 fl (normal, 80-94 fl)); and normal renal function (serum creatinin 42 μmol/L (normal, 31-68 μmol/L), urinary protein excretion 0.1 g/24 h (normal, < 0.3 g/24 h)). Tuberculin skin test, pathergy test, plasma lupus anticoagulant, anti-cardiolipins, direct Coombs test, angiotensin converting enzyme, ANA and ANCA were negative.
A chest X-ray showed a broad mediastinum, without pulmonary abnormalities. A CT-scan showed an enlarged subcarinal mediastinal mass branching towards both pulmonary hili, without parenchymal disease. The patient developed febrile episodes every afternoon (up to 39°C), and complained of mild myalgia. Diagnostic considerations included atypical pneumonia, tuberculosis, lymphoma, sarcoidosis, autoimmune and autoinflammatory disorders.
A bronchoscopy with transbronchial biopsy and bronchial alveolar lavage was performed. The biopsy results were not consistent with malignancy or sarcoidosis but were not conclusive. Therefore, a cervical mediastinoscopy was performed, and histological examination of the enlarged lymph node revealed no signs of malignancy, tuberculosis or sarcoidosis, but a reactive pattern with numerous lymphocytes, lymphoblasts and plasma cells. Culture of sputum, blood, stomach contents, bronchoalveolar lavage fluid and serology could not identify an infectious cause explaining the reactive lymphadenopathy.
Under the working diagnosis of medium-sized vessel vasculitis with moderate pulmonary hypertension as a consequence, the patient was treated with intravenous gamma globulin (2 g/kg) for two days, intravenous prednisolone (35 mg/day) and cyclophosphamide (750 mg/m2, once per month, 12 pulses), sildenafil (40 mg/day) and bosentan (125 mg/day). Anticoagulation therapy was initiated in the acute phase but stopped after one week. Ten days thereafter the patient developed recurrent hemoptysis.
Twenty-five days after initiation of the anti-inflammatory treatment, the ESR returned to the normal range; however, after five weeks the patient developed massive bleeding in his respiratory tract. The aneurysmal right bronchial artery was identified as the focus of the bleeding by digital substraction angiography and embolized with microspheres. The patient required mechanical ventilation and was treated in the intensive care unit for three weeks. After ten weeks he was sufficiently recovered to be discharged. The exercise tolerance was severely decreased but improved gradually as demonstrated by the results of the 6 minutes walk test. Seven weeks after embolization, the walked distance was 178 meters; eighteen months later this had improved to 442 meters. However, the walked distance is still below reported results from healthy age-matched males .
After the final cyclophosphamide pulse azathioprine was started (2 mg/kg/day, for 2 years). Steroids were tapered gradually and discontinued 18 months after initiation of therapy. No important side effects of the medication occurred. Currently, after eighteen months of treatment, the patient is still in remission. The inflammatory parameters are not elevated and fever is absent. Upon re-evaluation on CT scan, there were only minor residual vessel wall derangements visible at the site of the former aneurysms. The follow-up of the pulmonary hypertension was done indirectly by cardiac ultrasonography and showed no increase of pulmonary hypertension. Sildenafil and bosentan are continued. The papilledema had resolved, cerebral imaging was not repeated.
We present a case of recurrent hemoptysis and pulmonary hypertension in an 11-year-old boy. The symptoms of the patient appeared to be the result of an inflammatory destructive process solely affecting the medium sized pulmonary and bronchial vessels. However, the involvement of both pulmonary and systemic vessels makes classification of the disease difficult.
The vasculitis of medium-sized vessels described in this report might be classified as PAN because the patient met the full diagnostic criteria of childhood PAN, that include: angiographic or histologic abnormalities combined with myalgia, and symptoms suggesting involvement of a major organ system .
PAN is a vasculitis typically involving medium sized vessels and the disease is rare in childhood with an incidence of < 1 in 1 million . PAN most commonly involves skin, joints, peripheral nerves, gastrointestinal tract and kidney, and disease manifestations are diverse. Pulmonary involvement is rare but was described to occur in ~11% of juvenile systemic PAN cases . In the same study, 8 out of 56 (14%) juvenile PAN patients had aneurysms in central nervous system arteries. Pulmonary involvement in PAN includes arteritis of bronchial arteries, but diffuse alveolar damage and interstitial fibrosis have also been detected in autopsy cases . The risk of venous thrombosis in PAN is higher compared to the general population [12, 13], which may be attributable to the systemic inflammation. In the presented case, all prothrombotic factors examined (lupus anticoagulant, anti-cardiolipins) were negative. To our knowledge, the incidence of venous sinus thrombosis in PAN has not been studied.
Pediatric cases of Hughes Stovin Syndrome
PAA, CVST, DVT
PAA, CVST, DVT
We argue, given the symptoms described in the current and previous case reports, that it is more likely that HSS is a variant of PAN rather than BD. This would apply to children and adults, as the diagnostic criteria do not differ in this respect. The presented case fulfills the diagnostic criteria with angiographic abnormalities of medium-sized vessels, and myalgia. In other published HSS cases, the presence or absence of mylagia or one of the other minor criteria for the diagnosis of PAN, are not mentioned. The therapeutic approach to HSS is similar to that of PAN, as both respond well to cyclophosphamide courses . Our case illustrates the beneficial effect of a treatment regimen entailing a combination of high-dose steroids and cyclophosphamide pulses.
In summary, we present a case of isolated pulmonary vasculitis with involvement of both the pulmonary and bronchial vessels and concomitant dural venous sinus thrombosis in an 11-year-old boy. The presentation of pulmonary vasculitis with lymphadenopathy, fever, weight loss, and hemoptysis as presented in this report has a broad differential diagnosis, including infections, malignancies and inflammatory disease. This may well represent a case of HSS. Based on our findings and previous case reports we argue that HSS might be a disease closely related to PAN. We cannot support this speculation with histological findings, since it was impossible to obtain histology in the presented patient. Treatment with high-dose steroids and cyclophosphamide induced remission and thus might be an effective therapeutic regimen in (pediatric) cases of HSS.
Written informed consent was obtained from the patient's parents for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal
List of abbreviations
Erythrocyte sedimentation rate
Mean corpuscular volume
Anti-neutrophil cytoplasmic antibodies
pulmonary artery aneurysms
cerebral venous sinus thrombosis
deep venous thrombosis
No funding resources to declare
- Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncampagni A, Lazar C, Bilge I, Uziel Y: EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis. 2010, 69: 798-806. 10.1136/ard.2009.116657.View ArticlePubMedGoogle Scholar
- Ball GV, Bridges SL: Vasculitis. 2008, New York: Oxford University PressGoogle Scholar
- Chernick V: Pulmonary vasculitides in children. Ped Resp Rev. 2006, 7: S243-S244.View ArticleGoogle Scholar
- Erkan F, Gül A, Tasali E: Pulmonary manifestations of Behçet's disease. Thorax. 2001, 56: 572-578. 10.1136/thorax.56.7.572.PubMed CentralView ArticlePubMedGoogle Scholar
- Erkan D, Yazici Y, Sanders A, Trost D, Yazici H: Is Hughes-Stovin syndrome Behçet's disease?. Clin Exp Rheumatol. 2004, 22: S64-S68.PubMedGoogle Scholar
- Koné-Paut I, Yurdakul S, Bahabri S, Shafae N, Ozen S, Özdogan H, Bernard JL: Clinical features of Behçet's disease in children: An international collaborative study of 86 cases. J Pediatrics. 1997, 132: 721-725.View ArticleGoogle Scholar
- Emad Y, Ragab Y, Shawki A, Gheita T, El Marakbi A, Salama M: Hughes-Stovin syndrome: is it incomplete Behçet's?. Clin Rheumatol. 2007, 26: 1993-1996. 10.1007/s10067-007-0609-y.View ArticlePubMedGoogle Scholar
- Geiger R, Strasak A, Treml B, Gasser K, Kleinsasser A, Fischer V, Geiger H, Loeckinger A, Stein JI: Six-minute walk test in children and adolescents. J Pediatr. 2007, 150: 395-399. 10.1016/j.jpeds.2006.12.052.View ArticlePubMedGoogle Scholar
- Dolezalová P, Telekesova P, Nemcova D, Hoza J: Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey. J Rheumatol. 2004, 31: 2295-2299.PubMedGoogle Scholar
- Ozen S, Anton J, Arisoy N, Bakkaloglu A, Besbas N, Brogan P, Garcia-Consuegra J, Dolezalova P, Dressler F, Duzova A: Juvenile polyarteritis: results of a multicenter survey of 110 children. J Pediatrics. 2004, 145: 517-522. 10.1016/j.jpeds.2004.06.046.View ArticleGoogle Scholar
- Matsumoto T, Homma S, Okada M, Kuwabara N, Kira S, Hoshi T, Uekusa T, Saiki S: The lung in polyarteritis nodosa: a pathologic study of 10 cases. Hum Pathol. 1993, 24: 717-724. 10.1016/0046-8177(93)90007-4.View ArticlePubMedGoogle Scholar
- Allenbach Y, Seror R, Pagnoux C, Teixeira L, Guilpain P, Guillevin L, for the French Vasculitis Study Group: High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener's granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann Rheum Dis. 2009, 68: 564-567. 10.1136/ard.2008.099051.View ArticlePubMedGoogle Scholar
- Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ: Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record linkage study. BMC Medicine. 2011, 9: 1-10.1186/1741-7015-9-1.PubMed CentralView ArticlePubMedGoogle Scholar
- Hughes JP, Stovin PGI: Segmental pulmonary artery aneurysms with peripheral venous thrombosis. Brit J Dis Chest. 1959, 53: 19-27. 10.1016/S0007-0971(59)80106-6.View ArticlePubMedGoogle Scholar
- Roberts DH, Jiminez JF, Golladay ES: Multiple pulmonary artery aneurysms and peripheral venous thromboses - The Hughes Stovin syndrome. Pediatr Radiol. 1982, 12: 214-216. 10.1007/BF00999315.View ArticlePubMedGoogle Scholar
- International study group for Behçet's disease: Criteria for diagnosis of Behçet's disease. The Lancet. 1990, 335: 1078-1080.Google Scholar
- Lee J, Noh JW, Hwang JW, Kim H, Ahn JK, Koh EM, Cha HS: Successful cyclophosphamide therapy with complete resolution of pulmonary artery aneurysm in Hughes-Stovin syndrome patient. Clin Rheumatol. 2008, 27: 1455-1458. 10.1007/s10067-008-0951-8.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.